Dr. Denis R. Miller, an oncology and hematology expert, has joined Parexel Clinical Research Services, a business unit of Parexel International Corp., as a senior medical director. Dr. Miller will act as clinical practice leader and provide consultation to clients sponsoring clinical trials in hematology and oncology.

“Dr. Miller’s appointment to our global team of therapeutic experts demonstrates Parexel’s commitment to expanding our leadership in the oncology field,” said Mark A. Goldberg, president of Clinical Research Services and Perceptive Informatics at Parexel International. “In addition to enhancing our in-depth therapeutic knowledge, we are focused on advancing our clients’ cancer treatments through the integration of medical expertise with our world-class medical imaging capabilities, and Dr. Miller will be a vital asset in that effort.”

Dr. Miller has worked at several leading pharmaceutical companies, including Hoffmann-La Roche and Johnson & Johnson, as well as clinical research organizations, where he held senior positions in pharmaceutical R&D and clinical oncology. He has served in leadership roles at premier cancer centers, medical centers and hospitals including as chairman, Department of Pediatrics at Memorial Sloan Kettering Cancer Center.